November 14,
2018
Ultragenyx Announces Intent to Submit New Drug Application to U.S. FDA for UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Mid-2019
November 9,
2018
Ultragenyx to Present at Upcoming Investor Conferences
November 5,
2018
Ultragenyx Reports Third Quarter 2018 Financial Results and Corporate Update